Activation of PKC results in a rapid but transient increase in endothelin-1 release by human arterial endothelial cells, followed by a decrease likely due to PKC downregulation.
No takes yet. Share an insight, caveat, or question.
Does not support clinical practice changes; leaves open PKC-endothelin pathway as hypothesis-generating for vascular research.
Yoshiji Yamada (1997) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: